Bristol-Myers Squibb
Ken Riker is an accomplished professional with extensive experience in product quality within the biotechnology and pharmaceutical industries. Currently serving as Executive Director and Head of Cell Therapy Global Product Quality at Bristol Myers Squibb since March 2019, Ken previously held roles as Product Quality Director at the same company and Amgen. Prior experience includes positions as QC Manager at Immunex, QC Supervisor at ZymoGenetics, and QC Associate at NeoRx, contributing to antibody conjugation research. Ken Riker earned a BA in English from the University of Washington, with education spanning from 1982 to 1995.
This person is not in any teams
This person is not in any offices